Table 3

Clinical & demographic details
NMS patients (n = 13) Cases 1–5 “rapid dose escalators” (n = 5) Cases 6–13 “non rapid dose escalators” (n = 8)
Mean age, years [95% C.I.] 46.2 47.8 45.2
Male, n (%) 7 (53.8) 2 (40) 5 (62.5)
ICD 10 Diagnosis
F20 Schizophrenia n (%) 7 (53.8) 2 (40) 5 (62.5)
F30 Affective Disorders n (%) 3 (23.1) 2 (40) 1 (12.5)
F0 Organic Mental Disorder n (%) 2 (15.4) 0 (0) 2 (25)
F60 Disorder of Adult Personality & Behaviour n (%) 1 (7.7) 1 (20) 0 (0)
History of alcohol misuse, n (%) 5 (38.5) 2 (40) 3 (37.5)
History of substance misuse, n (%) 4 (30.8) 1 (20) 3 (37.5)
Compulsory Treatment, n (%) 5 (38.5) 2 (40) 3 (37.5)
History of non compliance, n (%) 9 (69.2) 3 (60) 6 (75)
Antipsychotic naïve, n (%) 1 (7.7) 1 (20) 0 (0)
History of extra pyramidal side effects, n (%) 8 (61.5) 2 (40) 6 (75)
Co prescribed oral antidepressant, n (%) 3 (23.1) 2 (40) 1 (12.5)
Co prescribed lithium, n (%) 2 (15.4) 1 (20) 1 (12.5)
Received IM medication, n (%) 5 (38.5) 2 (40) 3 (37.5)
Antipsychotic polypharmacy, n (%) 7 (53.8) 2 (40) 5 (62.5)
Required physical restraint, n (%) 5 (38.5) 2 (40) 3 (37.5)

Langan et al.

Langan et al. BMC Psychiatry 2012 12:214   doi:10.1186/1471-244X-12-214

Open Data